2 ASX All Ords shares cracking new 52-week highs on Tuesday

Do these healthcare shares have a place in your portfolio?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tuesday is shaping up to be rough one for many All Ordinaries Index (ASX: XAO) shares. Fortunately, though, not all companies that call the index home are suffering.

Indeed, two are soaring into the green to crack new 52-week highs.

Right now, the All Ords is down 0.2%, trading at 7,137.1 points.

So, which stocks are bucking the trend to reach long-forgotten heights? Let's take a look.

Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.

Image source: Getty Images

2 All Ords shares trading at 12-month highs

The first All Ords share posting a new 52-week high today is medical device developer Polynovo Ltd (ASX: PNV).

It's soaring 7.83% at the time of writing to trade at $2.48. However, earlier today, it hit $2.50 – marking an 8.7% gain and the highest the stock has been in 18 months.

Interestingly, there's been no news from the healthcare favourite to explain today's rise.

In fact, the last time the market heard price-sensitive news from Polynovo was in mid-December when the company announced the end of a $53 million capital raise – offering new shares for $1.90 apiece.

Thus, those who got in on the raise have already seen a 30% return on investment (ROI).

Joining Polynovo in posting a new 52-week high today is fellow All Ords healthcare share Aroa Biosurgery Ltd (ASX: ARX).

It reached its highest point since October 2021 earlier today, leaping to $1.175 – 2.2% higher than its previous close. It has since slipped slightly to $1.1725, representing a 1.96% gain.

Also, like Polynovo before it, the company hasn't released any news to explain its latest gain.

The last piece of price-sensitive news from Aroa Biosurgery, detailing its half-year performance, dropped in late November.

Then, the company announced its product sales grew 44% year-on-year while its normalised earnings before interest, tax, depreciation, and amortisation (EBITDA) was positive.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PolyNovo. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

An older couple enjoying their retirement come together in their warm heated home with fire cracker sparklers.
52-Week Highs

These ASX stocks have hit the ground running in June – can they keep rising?

Where to next for these red hot shares?

Read more »

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
52-Week Highs

3 top ASX shares at 52-week highs I'd still buy

A 52-week high should not automatically scare investors away if the business still has room to improve over time.

Read more »

Man smiling on top of rocks with mountains in the background.
52-Week Highs

Are these ASX shares a buy, hold or sell after hitting fresh 52-week highs?

Is there any upside left for these shares?

Read more »

Digital rocket on a laptop.
52-Week Highs

Up 300% in a year, this ASX tech stock just hit its highest level since 2023

Investors are chasing this ASX tech stock after a stunning rally.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
52-Week Highs

Which of these ASX shares hitting record highs is the best buy right now?

These ASX shares are red hot.

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
52-Week Highs

Are Telstra and these ASX shares a buy, hold or sell after hitting new yearly highs?

Is there any more upside for these ASX shares?

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
52-Week Highs

Are these ASX shares a buy, hold or sell after rocketing to record highs last week?

These stocks have all doubled in the last year.

Read more »

Two friends giving each other a high five at the top pf a hill.
52-Week Highs

Can these ASX shares hitting record highs keep climbing?

Here's what experts are saying about these companies.

Read more »